BRPI0912768A2 - vacinas de poliproteínas recombinante para o tratamento e diagnóstico de leishmaniose - Google Patents
vacinas de poliproteínas recombinante para o tratamento e diagnóstico de leishmanioseInfo
- Publication number
- BRPI0912768A2 BRPI0912768A2 BRPI0912768A BRPI0912768A BRPI0912768A2 BR PI0912768 A2 BRPI0912768 A2 BR PI0912768A2 BR PI0912768 A BRPI0912768 A BR PI0912768A BR PI0912768 A BRPI0912768 A BR PI0912768A BR PI0912768 A2 BRPI0912768 A2 BR PI0912768A2
- Authority
- BR
- Brazil
- Prior art keywords
- leishmaniasis
- vaccines
- diagnosis
- treatment
- recombinant polyprotein
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/002—Protozoa antigens
- A61K39/008—Leishmania antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5507908P | 2008-05-21 | 2008-05-21 | |
PCT/US2009/044098 WO2009143006A1 (en) | 2008-05-21 | 2009-05-15 | Recombinant polyprotein vaccines for the treatment and diagnosis of leishmaniasis |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0912768A2 true BRPI0912768A2 (pt) | 2016-05-17 |
Family
ID=41020810
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0912768A BRPI0912768A2 (pt) | 2008-05-21 | 2009-05-15 | vacinas de poliproteínas recombinante para o tratamento e diagnóstico de leishmaniose |
Country Status (7)
Country | Link |
---|---|
US (1) | US8425919B2 (pt) |
EP (1) | EP2300051B1 (pt) |
AR (1) | AR073170A1 (pt) |
BR (1) | BRPI0912768A2 (pt) |
ES (1) | ES2528928T3 (pt) |
HK (1) | HK1155075A1 (pt) |
WO (1) | WO2009143006A1 (pt) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007121184A2 (en) | 2006-04-10 | 2007-10-25 | The Infectious Disease Research Institute Inc. | Compounds and methods for diagnosis and treatment of leishmaniasis |
BRPI0603490B1 (pt) * | 2006-07-21 | 2018-04-24 | Universidade Federal De Minas Gerais | Vacina recombinante contra a leishmaniose visceral canina |
US8603808B2 (en) * | 2008-05-08 | 2013-12-10 | Merial Limited | Leishmania vaccine using sand fly salivary immunogen |
US8410258B2 (en) | 2008-05-21 | 2013-04-02 | Infections Disease Research Institute | Recombinant polyprotein vaccines for the treatment and diagnosis of leishmaniasis |
PT2291394T (pt) | 2008-07-03 | 2017-06-05 | Infectious Disease Res Inst | Proteínas de fusão e seus usos no diagnóstico e tratamento de leishmaniose |
EA201390676A1 (ru) * | 2010-11-08 | 2013-11-29 | Инфекшес Дизиз Рисерч Инститьют | Вакцины, содержащие полипептиды неспецифической нуклеозидгидролазы и стерол 24-c-метилтрансферазы (smt), для лечения и диагностики лейшманиоза |
JP6438396B2 (ja) * | 2012-08-30 | 2018-12-12 | メリアル インコーポレイテッド | 不活化ワクチンを作製するための、ならびに組換えタンパク質をリフォールディング/可溶化させるための高圧デバイスおよび方法 |
EP2978447B1 (en) * | 2013-03-28 | 2019-05-08 | Infectious Disease Research Institute | Vaccines comprising leishmania polypeptides for the treatment and diagnosis of leishmaniasis |
EP2981287A4 (en) * | 2013-03-28 | 2017-03-08 | Infectious Disease Research Institute | Vaccines comprising leishmania polypeptides for the treatment and diagnosis of leishmaniasis |
US9149521B2 (en) | 2013-09-25 | 2015-10-06 | Sequoia Sciences, Inc. | Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections |
US9017698B2 (en) | 2013-09-25 | 2015-04-28 | Sequoia Sciences, Inc. | Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections |
US9504743B2 (en) | 2013-09-25 | 2016-11-29 | Sequoia Sciences, Inc | Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections |
US9149522B2 (en) | 2013-09-25 | 2015-10-06 | Sequoia Sciences, Inc. | Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections |
AU2014373928C1 (en) | 2013-12-31 | 2020-12-17 | Access To Advanced Health Institute | Single vial vaccine formulations |
KR20220125149A (ko) | 2019-05-25 | 2022-09-14 | 액세스 투 어드밴스드 헬스 인스티튜트 | 애주번트 백신 에멀션을 분무 건조시키기 위한 조성물 및 방법 |
US20240050561A1 (en) | 2020-12-23 | 2024-02-15 | Access To Advanced Health Institute | Solanesol vaccine adjuvants and methods of preparing same |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU7529194A (en) * | 1993-09-03 | 1995-03-22 | Mcgill University | Differentially expressed (leishmania) genes and proteins |
US6613337B1 (en) * | 1997-02-12 | 2003-09-02 | Corixa Corporation | Leishmania antigens for use in the therapy and diagnosis of leishmaniasis |
US6525186B2 (en) * | 1998-12-23 | 2003-02-25 | C.B.F. Leti S.A. | Chimeric gene formed of the DNA sequences that encode the antigenic determinants of four proteins of L. infantum, useful of serologic diagnosis of canine leishmaniosis and protein obtained |
US20040170636A1 (en) * | 2001-03-29 | 2004-09-02 | Greg Matlashewski | Leishmania vaccines |
GB0321615D0 (en) * | 2003-09-15 | 2003-10-15 | Glaxo Group Ltd | Improvements in vaccination |
ES2298829T3 (es) * | 2003-10-24 | 2008-05-16 | Mologen Ag | Agente para el tratamiento de infecciones por leishmania. |
EP2068918B1 (en) * | 2006-09-26 | 2012-05-02 | Infectious Disease Research Institute | Vaccine composition containing synthetic adjuvant |
MX2009005381A (es) * | 2006-11-21 | 2009-06-30 | Merial Ltd | Vacuna para leishmania canina. |
US8916168B2 (en) * | 2007-07-13 | 2014-12-23 | Infectious Disease Research Institute | Leishmania sterol 24-c-methyltransferase compositions for the prevention, treatment and diagnosis of leishmaniasis |
US8410258B2 (en) * | 2008-05-21 | 2013-04-02 | Infections Disease Research Institute | Recombinant polyprotein vaccines for the treatment and diagnosis of leishmaniasis |
PT2291394T (pt) * | 2008-07-03 | 2017-06-05 | Infectious Disease Res Inst | Proteínas de fusão e seus usos no diagnóstico e tratamento de leishmaniose |
-
2009
- 2009-05-15 ES ES09751235.4T patent/ES2528928T3/es active Active
- 2009-05-15 BR BRPI0912768A patent/BRPI0912768A2/pt not_active Application Discontinuation
- 2009-05-15 EP EP09751235.4A patent/EP2300051B1/en not_active Not-in-force
- 2009-05-15 WO PCT/US2009/044098 patent/WO2009143006A1/en active Application Filing
- 2009-05-15 AR ARP090101761A patent/AR073170A1/es unknown
- 2009-05-15 US US12/466,580 patent/US8425919B2/en active Active
-
2011
- 2011-09-02 HK HK11109344.1A patent/HK1155075A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
AR073170A1 (es) | 2010-10-20 |
ES2528928T3 (es) | 2015-02-13 |
WO2009143006A1 (en) | 2009-11-26 |
HK1155075A1 (en) | 2012-05-11 |
EP2300051A1 (en) | 2011-03-30 |
US20090291099A1 (en) | 2009-11-26 |
EP2300051B1 (en) | 2014-11-12 |
US8425919B2 (en) | 2013-04-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0912768A2 (pt) | vacinas de poliproteínas recombinante para o tratamento e diagnóstico de leishmaniose | |
BR112012004546A2 (pt) | "terapêutica por proteínas ligantes dll4-ligantes" | |
BRPI0813212A2 (pt) | Métodos de tratamento de doenças e distúrbios mediados por serotonina | |
BRPI1012116A2 (pt) | composição farmacêutica para o tratamento de doenças cardíacas | |
BRPI1016147A2 (pt) | sistema intrauterino para uso no tratamento de uma condição médica, e, método para a fabricação de um sistema intrauterino | |
BRPI1013698A2 (pt) | métodos para tratamento com o uso de terapia de combinação | |
BRPI0919288A2 (pt) | teriapia de combinação para tratamento de diabetes e condições relacionadas. | |
BRPI0908026A2 (pt) | Métodos para o tratamento de doenças do intestino | |
BRPI0911604A2 (pt) | vacinas de polipeptídeo de flagelina | |
DK2448637T3 (da) | Anvendelse af ét fytocannabinoid eller en kombination af fytocannabinoider til behandling af epilepsi | |
DK3067064T3 (da) | Modificerede rsv-f-proteiner og fremgangsmåder til anvendelse deraf | |
CR10571A (es) | Vacuna virica recombinante | |
BR112012013260A2 (pt) | dispositivo usado para o tratamento de rinite através de iluminação bioestimulativa | |
BR112013018754A2 (pt) | combinação de componentes para a prevenção e tratamento de fragilidade | |
BRPI0718548A2 (pt) | Estabilização de vacinas por liofilização | |
BR112012003844A2 (pt) | vacinas de pttv e diagnóstico | |
BR112012001797A2 (pt) | composto bicíclico e uso do mesmo para propósitos médicos | |
BR112012004836A2 (pt) | pirazinilpiridinas úteis para o tratamento de doenças proliferativas | |
BRPI0816712A2 (pt) | terapia de intervalo para o tratamento de tinnitus | |
BRPI0914782A2 (pt) | peptídeos de epítopos de cdca1 e vacinas contendo os mesmos | |
BRPI1008887A2 (pt) | peptídeos de foxm1 e vacinas contendo os mesmo | |
BRPI0919236A2 (pt) | terapêutica e vacinas de combinação de gas | |
BRPI0912687A2 (pt) | uso de bactéria probiótica para o tratamento de hiperhomocisteinaemia | |
FI20095134A (fi) | Menetelmä pitolaitteen käyttämiseksi ja pitolaite | |
BRPI0913015A2 (pt) | transportador de tecido para uso em cirurgias de redução gástrica e o método de uso associado |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07E | Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
B11E | Dismissal acc. art. 34 of ipl - requirements for examination incomplete | ||
B11T | Dismissal: dismissal of application maintained |